- Home
- DNLI vs SBLK Comparison
DNLI vs SBLK Comparison
Compare DNLI & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | SBLK |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.4B |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | DNLI | SBLK |
|---|---|---|
| Price | $20.47 | $31.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | ★ $34.33 | $25.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-20-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.56 |
| Revenue Next Year | $408.85 | N/A |
| P/E Ratio | ★ N/A | $47.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.78 | $16.72 |
| 52 Week High | $27.30 | $32.88 |
Technical Indicators
Market Signals| Indicator | DNLI | SBLK |
|---|---|---|
| Relative Strength Index (RSI) | 30.01 | 57.16 |
| Support Level | $18.86 | $29.42 |
| Resistance Level | $20.84 | $32.88 |
| Average True Range (ATR) | 0.70 | 0.76 |
| MACD | -0.25 | -0.05 |
| Stochastic Oscillator | 16.59 | 52.77 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. The firm generates the majority of its revenue from Time charters and Voyage charters.